Healthcare >> Analyst Interviews >> September 30, 1999
EMIL G. WESTERGAARD is a Director and head of medical technology equity
research with Warburg Dillon Read LLC. Previously, he was associated
with Bear Stearns & Company and worked as Editor of The International
Med-Tech Directory of Publicly Owned Healthcare Companies. A Chartered
Financial Analyst and a member of the NYSSA, Mr. Westergaard holds a
Bachelor of Liberal Arts degree from the University of Chicago. Profile
TWST: Tell us about the approach that you and Warburg Dillon Read taketo medical technology.
Mr. Westergaard: At Warburg Dillon Read, we have established broad
global medical technology